Introduction. One indicator for fetal risk of mortality is intrauterine growth restriction (IUGR). Whether markers reflecting the impact of growth restriction on the cardiovascular system, computed from a Doppler-derived heart rate signal, would be suitable for its detection antenatally was studied. Material and methods. We used a cardiotocography archive of 1163 IUGR cases and 1163 healthy controls, matched for gestation and gender. We assessed the discriminative power of short-term variability and long-term variability of the fetal heart rate, computed over episodes of high and low variation aiming to separate growth-restricted fetuses from controls. Metrics characterizing the sleep state distribution within a trace were also considered for inclusion into an IUGR detection model. Results. Significant differences in the risk markers comparing growth-restricted with healthy fetuses were found. When used in a logistic regression classifier, their performance for identifying IUGR was considerably superior before 34 weeks of gestation. Long-term variability in active sleep was superior to short-term variability [area under the receiver operator curve (AUC) of 72% compared with 71%]. Most predictive was the number of minutes in high variation per hour (AUC of 75%). A multivariate IUGR prediction model improved the AUC to 76%. Conclusion. We suggest that heart rate variability markers together with surrogate information on sleep states can contribute to the detection of earlyonset IUGR.
Introduction
Intrauterine growth restriction (IUGR) is a pathological decrease in fetal growth rate whereby the fetus cannot reach its full genetic growth potential, and is associated with significantly increased mortality and morbidity (1, 2) .
Developing countries carry the highest burden of perinatal mortality (98%) (3), of which a significant proportion can be attributed to IUGR-based complications (IUGR prevalence estimated >10%) (4) . Key reasons for this include lack of systematic screening for IUGR and robust referral.
In the context of a well-equipped hospital several measures are typically available to the clinician when screening for, diagnosing, and managing IUGR. In addition to maternal history, available tests include symphysis fundal height measurement, the biophysical profile score, and fetal ultrasound biometry and multivessel Doppler studies.
In the absence of sophisticated equipment in lowresource settings, IUGR detection is limited to the identification of maternal risk factors and the measurement of fundal height over time. The latter has high inter-observer and intra-observer variability (5) and its diagnostic value has been reported to show highly varied results, even for relatively well-trained clinical staff (6) .
Given the scarcity of information available to healthcare workers in low-resource settings, additional insight into the developmental status of the fetus may provide valuable decision support. The fetal cardiac signal is the most accessible source of physiological information on the well-being of the fetus. A low-cost method to record this signal is through the use of hand-held Doppler devices.
Growth restriction remains an area of active research due to the complexity surrounding accurate identification and adequate management. Several researchers have investigated either the detection of growth restriction (7) (8) (9) (10) (11) (12) (13) (14) or its management (15) (16) (17) (18) (19) by assessing its impact on the fetal cardiovascular system. One extensively researched measure of fetal well-being is heart rate variability (HRV).
Studies assessing the difference in HRV marker values between IUGR and healthy fetuses have however been largely underpowered, rendering any generalization of results beyond the subjects studied unfeasible (7) (8) (9) (10) (11) (12) (13) (14) .
We therefore set out to investigate whether analysis of the Doppler-based fetal heart rate signal (on a convenience sample of cardiotocograph traces) can contribute to the detection of IUGR risk.
Material and methods

Database
To confirm the utility of selected markers for the detection of IUGR fetuses antepartum, we used the extensive computerized cardiotocography (cCTG) archive of fetal heart rate variables collected between 1990 and 2011 at the John Radcliffe Hospital in Oxford, UK. The cardiotocograms were recorded and analyzed using the Sonicaid FetalCare system (Huntleigh Healthcare Ltd, Diagnostic Products Division, Cardiff, UK).
All fetuses with a birthweight under the third centile [adjusted Yudkin birthweight centile, which is specific for both gender and gestational age (20) ] were considered growth-restricted and included in the data set for analysis. All cCTG traces selected were the last recording of each woman before delivery. The control group of normal fetuses was matched for both gender and gestational age at the time of recording. The resultant study data set of 1163 cases and 1163 control cases is the largest of its kind reported on by more than a factor of 10.
To confirm an initial assumption that IUGR fetuses can be better distinguished from healthy fetuses earlier in gestation the study database was divided into two subsets. The first subset included fetuses with their last trace recorded at or before 34 weeks, the second subset comprised all fetuses with their last trace recorded after 34 weeks of gestation. The characteristics of the two populations are summarized in Table 1 .
cCTG markers
Fetal short-term variability (STV) and long-term variability (LTV) were readily available in the database, computed by the cCTG system according to Dawes and Redman (21) .
The fetal heart rate shows change corresponding to the respective biological sleep state. A healthy fetus cycles through episodes of active and quiet sleep from 28 weeks of gestation, which the Dawes/Redman system screens for as part of its automated analysis (21) . Periods of active sleep are associated with fetal movement and high HRV. Quiet sleep in contrast is characterized by the absence of movement and low HRV (22) .
An episode of active sleep is an indicator of fetal wellbeing and is one of the key criteria used in the Dawes/ Redman system to advise on normality.
Key Message
Doppler-based heart rate variability markers together with information on sleep states can contribute to the detection of early-onset intrauterine growth restriction (IUGR). This supports the notion of developing screening algorithms for resource-poor settings with high IUGR prevalence based on low-cost technology.
If criteria are met, the system can be switched off, resulting in recordings of dissimilar length, typically between 10 and 60 min, where short traces contain a high percentage of active sleep and longer traces can be composed of, for example, 54 min of quiet sleep with low variability followed by only a short period of high variation. Overall measures of STV and LTV calculated for each trace therefore contain a bias due to a potentially large sampling error dependent on the recording length. STV and LTV were therefore computed as average over periods of active and quiet sleep in each trace.
Metrics characterizing the trace composition, such as the number of episodes of quiet, active and indeterminate sleep and their average duration, have been included as features in the discrimination model (all features are listed in Table 2 ).
Statistical analyses
As the distribution of the selected risk markers STV and LTV is non-Gaussian, their correlation was assessed using Spearman's rho. It was investigated whether the differences in risk marker values were statistically significant in the growth-restricted and normal populations using the nonparametric Mann-Whitney U-test, visualized with box plots. A p-value of <0.05 was selected as the level of significance.
The data were quasi-randomly divided into a training and test set (70/30 split). Binary logistic regression classifiers were trained for all individual single risk markers, as well as for every possible combination including gestational age (in weeks) at time of recording using five-fold cross-validation on the training set. The associated average area under the receiver operator curve (AUC) was computed on the held out folds for comparison of the predictive power of the risk markers and their combinations. The AUC statistic of the overall best-performing feature combination was compared for statistical significance with the AUC of the remaining classifiers achieving the best result provided the selection of input variables. Additionally, the AUC statistic of the best-performing single marker was compared for statistical significance with the AUC of the remaining. Significance values were adjusted with the Holm-Bonferroni method to correct for multiple testing and falsely rejecting the null hypothesis (Type 1 errors) (23) . The best performing single-and multiple-feature classifier was tested on a held-out test set and the AUC was reported for comparison with the training results.
Data pre-processing
The data set contained a total of 387 traces (314 IUGR and 73 healthy controls) with no episodes of high variability and 1410 traces (580 IUGR and 820 healthy controls) with no episodes of low variability. Traces with no high variability indicate that the monitored fetus did not enter a period of high heart rate variation within 60 min of recording. Table 2 . Selected features from cardiotocographic risk markers, trace characteristics, and patient information for intrauterine growth restriction classification.
Risk marker (feature) (unit) Definition
LTVinHi (ms) The long-term variability averaged over periods of high heart rate variation. STVinHi (ms)
The short-term variability averaged over periods of high heart rate variation. LTVinLo (ms)
The long-term variability averaged over periods of low heart rate variation. STVinLo (ms)
The short-term variability averaged over periods of low heart rate variation. NoHiEpi (ph)
The number of high variation episodes normalized by the length of the recording. NoLoEpi (ph)
The number of low variation episodes normalized by the length of the recording.
The number of minutes in high variation normalized by the length of the recording.
The number of minutes in low variation normalized by the length of the recording. AvgDurHi (min)
The average duration of episodes of high variation. AvgDurLo (min) The average duration of episodes of low variation. HiEpiStrt (min)
The onset of the first high variation episode. RecGest (weeks) The gestational age as estimated at time of recording.
ph, per hour. Fetuses that do not enter a phase of active sleep within 1 h may be suspected of being compromised; they are therefore of particular interest in this investigation and should be included in the analysis. The majority of traces with no low variation are traces that have met criteria after an episode of high variability and have been terminated before a period of low activity could occur. The absence of low variation in a trace does not therefore allow for assumptions concerning fetal well-being to the same degree. However, STV and LTV during episodes of low heart rate variation may contain information on the severity of compromise. Substitute LTV and STV values were therefore estimated for both "missing" high and low periods. Substitution estimates were established based on the data available. For LTV in active sleep episodes (LTVinHi) the lowest value of existing LTVinHi measures was identified in each gestational age group with 10 or more traces available. A regression line was fitted and LTVinHi substitute values were computed for each week of gestation.
This approach was based on the assumption that the minute ranges in traces without an identified episode of high variability would have always been equal to or lower than this constructed threshold, as they would have otherwise been classified as being of high variation.
The same approach was used to estimates substitutes for LTVinLo and STVinHi. No clear threshold could be identified in short-term variability in quiet sleep episodes; substitute values were inferred from a regression line fitted to the mean of existing STVinLo measures instead.
Compared with the thresholds used in the cCTG analysis to classify periods of varying variability, as described by Pardey et al. (21) , the substitute values appear to be a reasonable choice. LTVinHi substitute values lie above the 32 ms and LTVinLo below the 30 ms reported.
Ethical approval
Ethics approval to use this database was given by NRES Committee South Central -Oxford A (REC Reference 13/SC/0153).
Results
The average distribution of episodes of high, low and indeterminate variability per gestational age group is shown in Figure 1 . In accordance with previous studies, an increase of active periods with maturation of the fetus, concomitant with its sleep organization, is clearly visible. This is true for both IUGR and normal traces. IUGR fetuses show a lower percentage of high variability (active sleep) compared with the normal population, in particular before 35 weeks of gestation.
Variability features appear to discriminate better earlier in gestation, in both male and female traces. This can be observed in the example box plots showing STV averaged over episodes of active sleep ( Figure 2) . As expected the quality of risk markers declined with increasing gestational age.
The performance of individual features for 23-34 weeks of gestation is listed in Table 3 . The number of minutes in high variation per hour (HiMinph) was most predictive with an AUC of 75% on the training set and 73% on the test set. HiMinph was statistically not significantly superior to the variability risk markers in active sleep, LTVinHi (74% training, 72% test) and STVinHi (71% training, 71% test). Both LTVinHi and STVinHi were found to be significantly different in IUGR traces compared with normal controls (p < 0.01). The AUC of multivariate models also declined with increasing gestational age. The model including the features gestational age, LTV, and STV in high variation episodes, the average duration in high variation, and the number of high episodes in the trace could improve the discriminative performance to 77% on the training set and 76% on the test set. The results are summarized in Table 4 , including those for 35-42 weeks of gestation for comparison.
The correlation between HRV markers was assessed in those traces containing periods of both low and high variability. The correlation in IUGR and normal traces was investigated separately to uncover whether relationships depend on the developmental state of the fetus. LTVinHi and STVinHi were found to be correlated in both IUGR traces and normal traces, but to a greater extent in the control group (+0.627, p < 0.001 and +0.765, p < 0.001, respectively). LTVinLo and STVinLo also showed a correlation in both traces of growthrestricted fetuses and healthy controls (+0.690, p < 0.001 and +0.585, p < 0.001, respectively).
Discussion
Our aim was to evaluate the utility of a novel combination of Doppler-based fetal HRV markers to identify fetal growth restriction. Analysis of our extensive data set confirmed that the distribution of marker values differs significantly in growth-restricted fetuses compared with normal controls, also when averaging over periods of active and quiet sleep, respectively.
The Dawes/Redman system applies an automated approach to the detection of fetal activity states based on the presence of accelerations and long-term variability measures tested against age-specific thresholds (21) . The alternative method of sleep state assessment described by Nijhuis et al. (24) relies on experts visually scoring fetal heart rate traces according to defined patterns. Multi- expert annotations were not feasible in the context of this investigation and with a view to translating this research to a low-resource environment, an automated approach was favored. Sleep organization is part of the fetal maturation process. It has been described in the literature that sleep states can only be reliably identified in the second half of the third trimester by pattern assessment (at around 36 weeks of gestation) (24) ; the documentation of the Dawes/Redman system reports cycles of active and quiet sleep (high and low variation) to be present from 28 weeks onwards. Whether episodes of high and low variation in younger and compromised fetuses in this analysis truly represent respective sleep states is unknown. However, a clear difference between IUGR and healthy fetuses in trace composition could be observed in our study and the low percentage of high variability in IUGR fetuses may well be interpreted as delayed or compromised sleep state organization as observed in literature (25, 26) .
The importance of activity states in the analysis of variability markers was suspected and could be confirmed in the investigation. The univariate model outcomes of markers computed for individual episodes of high and low variability have revealed the superior discriminative power of markers associated with active compared with quiet sleep episodes.
This indicates that the fetal behavioral state may confound HRV analysis in general. This has also been observed by Sriram et al. (27) . Two investigations could be identified that took sleep state information into account when analyzing the difference in HRV metrics in IUGR and normal fetuses (13, 27) . Both found their respective metrics under investigation to be lower in growth-restricted compared with normal fetuses and both included fetuses of less than 36 weeks of gestation. A direct comparison of results was not possible as previous studies were based on magnetocardiogram data and sleep state identification was based on expert review.
This investigation could confirm the dependence of HRV markers on gestational age, which has been reported in the literature (7, 12) . Risk marker values increased with gestational age in both growth-restricted and normal cases. The rate of change in compromised fetuses was, however, much higher with marker values being considerably lower earlier in gestation and approximating to control values towards term.
The results suggest that early-onset IUGR (≤34 weeks of gestation) and late-onset IUGR (>34 weeks of gestation) do not impact the fetal cardiovascular system in the same way.
The study outcomes indicate that HRV markers together with information on sleep states might contribute to the detection of early-onset IUGR. The multivariate classifier is of acceptable clinical utility [with an AUC of >0.75 (28)]. Identifying early-onset IUGR is of particular importance in settings where prevalence is high due to potentially addressable factors such as malnutrition or substance abuse. Positive perinatal outcomes have recently been reported for this high-risk group (29) and attributed to advances in monitoring and neonatal care. However, even relatively simple interventions, such as targeted nutritional programs, may lead to significant impacts in IUGR rates. Appropriate timely referral is therefore of utmost importance. Results are reported on a held out test set after training using fivefold cross-validation on training data (70/30 split). The best performing feature, the minutes per hour in high variation (HiMinph), was significantly superior to gestational age and markers associated with low variation episodes (p < 0.01), with the exception of LoMinph. No difference was found when comparing with features also derived from high-variability episodes. Gender has been excluded from the analysis as it will not be available in the anticipated use context. a All features are defined in Table 2 . Results are reported on a held out test set after training using fivefold cross-validation on training data (70/30 split). AUC, areas under the curve; others are listed in Table 2 .
a All features are defined in Table 2 . The difficulty of detecting late-onset IUGR has been previously noted in relation to other monitoring modalities, such as umbilical artery Doppler (12, 30) . This evidence, together with the lower performance of our approach in the late stages of pregnancy, indicates that alternative Doppler-based identifiers should be a priority for future research.
We note several limitations in our study. First, we note that this is a retrospective study based on a large convenience sample; subjects were not recruited specifically for the purposes of identifying IUGR. As such, a prospective study will be needed to confirm our approach. Second, the work includes population-specific growth charts used for the identification of IUGR babies; consideration of the appropriateness of growth curves is required when translating the presented findings to other study populations. The patients were drawn from a population of mostly white UK residents, and therefore the metrics may not apply to any demographic that is significantly different. It is important to note that IUGR is a complex phenomenon, its etiology is wide ranging and challenges surrounding differentiation from small-for-gestational age babies persist. However, regardless of the etiology of IUGR, we expect to see fetal heart rate changes (a lack of maturation of the central nervous system relative to gestational age) indicative of growth restriction that suggests onward referral to identify the etiology and hence the appropriate action. The key difference will be that there may be a rate of change of maturation related to the effect that may require a recalibration of the features and coefficients of the model. Third, fundal height measurements were not available in the data set and therefore could not be included in our study for comparative effectiveness. However, as noted earlier, evidence around this method is highly varied. Nevertheless, there may indeed be independent predictive power in fundal height measures, and future work should, if practical, include fundal height as an additional parameter in our model to investigate if the measure provides additional predictive power for a group of midwives with a given training level. Fourth, we also note that fetal growth restriction was defined by the newborn's birthweight centile (<3rd centile) only. Antenatal measures to assess IUGR, such as Doppler velocimetry of fetal vessels and maternal uterine artery, were not accounted for because they were not available.
Finally, although we acknowledge that 0.76 is a modest AUC, we believe that the results provide good evidence to suggest that fetal heart rate-based assessment may be a constituent part of any low-cost IUGR screening method. New studies, currently under way, are aimed at adding additional non-HRV metrics to improve this AUC.
The low temporal resolution of the cardiotocograph's fetal heart rate signal is suspected to be a major limitation for IUGR detection. Ongoing work therefore concerns the development of raw Doppler-based, pseudo beat-to-beat, fetal heart cycle segmentation. We hypothesize that risk markers derived from such a signal can improve IUGR identification and we are in the process of collecting (hand-held) Doppler data to test this hypothesis. The translation of this research to the use of hand-held Doppler in low-resource environments is a work in progress (31) . 
